Multi-site randomised controlled trial of fluoxetine in children and adolescents with autism.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/607332

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Fluoxetine is a medication that is increasingly used in children with autism in an attempt to control repetitive behaviours, which substantially interfere with daily functioning and quality of life. However clinicians working in the field of autism and goverment regulatory bodies (such as the TGA) require evidence of the efficacy of fluoxetine for this indication. This study aims to determine this, thereby addressing an important gap in clinical knowledge.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $499,482.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Mental Health

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Autism | Autism Spectrum Disorder | Behaviour | Children | Drug Efficacy | Multicentre | Randomised Controlled Trial

Related Links